Is hyperuricemia associated with the development of the composite outcomes of new cardiovascular events and chronic allograft nephropathy?
These results suggest an important association between hyperuricemia at 6 months after kidney transplantation and new cardiovascular events and CAN in patients with decreased allograft function.
Cys-LTs do not transactivate EGFR but have a broader capability to synergize with receptor tyrosine kinase pathways.